Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.
about
Endometrial cancer: what is new in adjuvant and molecularly targeted therapy?Controversies in the management of endometrial carcinoma.Second-line chemotherapy for advanced or recurrent endometrial carcinoma previously treated with paclitaxel and carboplatin, with or without epirubicinInvestigating the relative efficacies of combination chemotherapy of paclitaxel/carboplatin, with or without anthracycline, for endometrial carcinomaEverolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO.Pharmacotherapy of endometrial cancer.Ixabepilone for the treatment of endometrial cancer.A molecular carrier to transport and deliver cisplatin into endometrial cancer cells.Should all patients with serous and clear cell endometrial carcinoma receive adjuvant chemotherapy?Taxane-sensitivity of ovarian carcinomas previously treated with paclitaxel and carboplatin.Adjuvant sequential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, multicenter phase-II study of the NOGGO (North-Eastern German Society of Gynaecological Oncology).Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model.Thoracic laminectomy with spinal fixation in a nonambulatory patient with metastatic vertebral tumor from endometrial carcinoma.Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group.
P2860
Q33633962-85157EB6-434F-4679-95C6-022EB243F785Q33960894-C049B93C-54DB-47AB-B0AC-A950D437B125Q34724590-4FAF1104-B1F4-42AA-A0A7-AC30DB57506FQ35886274-C4F461B2-A252-4A51-83A3-6BAC77DBA535Q36857470-61B1EA9B-1805-40FE-B6F8-CD88AD40262EQ37544822-94AA998E-8BAF-40A6-AE83-913216B0875BQ38763500-CAD67D2B-4E09-423B-BF85-0CF368907565Q39409872-45F5C08C-ACF8-4296-A492-C5D9624EDACBQ39811675-0BA1B2BF-4910-4091-A1D5-AAD7A02ABCDFQ43409591-744B4807-291E-4395-8CAD-6FCE179C14FDQ46115402-6B3B4D51-A207-45D1-9289-99EDC2CF3EF5Q47736935-5B5CB739-A1B8-4A63-934A-3F12E1DB6E3CQ53087043-92F63425-4B8B-476D-BC81-962F69B2B82DQ55005815-00D17B1E-43F3-4C4C-A7F8-9A3B08A451B8
P2860
Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.
@ast
Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.
@en
type
label
Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.
@ast
Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.
@en
prefLabel
Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.
@ast
Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.
@en
P2093
P1433
P1476
Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.
@en
P2093
C Sykiotis
D Kassanos
D Pectasides
E Pectasides
G Papaxoinis
J Panayiotidis
P Gouveris
P304
P356
10.1016/J.YGYNO.2008.01.028
P407
P577
2008-03-04T00:00:00Z